Zimmer Holdings (NYSE:ZMH)‘s stock had its “outperform” rating reiterated by research analysts at Oppenheimer in a report released on Monday. They currently have a $124.00 target price on the stock. Oppenheimer’s target price points to a potential ... · 5/19/2015
Oppenheimer reaffirmed their outperform rating on shares of Zimmer Holdings (NYSE:ZMH) in a research note issued to investors on Monday. The firm currently has a $124.00 price target on the stock. “With the Biomet acquisition expected to be … · 5/20/2015
Orthopedics company Zimmer Holdings (ZMH) announced Thursday that it is buying privately held Biomet for $13.35 billion, driving its stock up more than 12% in morning trading on the stock market even though its Q1 sales missed expectations. The …
Investors Business Daily · ByAmy Reeves · 4/25/2014
More from Bing News
Jay Hawk enjoyed a 12-year professional financial markets career incorporating extensive first hand futures and options experience obtained by trading in the stock, commodity and forex markets on U.S. exchanges. Since retiring as a full-time financial ...
Investor Guide · 4/25/2014
The investment practices of Tudor Investment Corp go back to 1980 and the company filed its latest SEC 13F filing on November 14 with American International Group Inc (NYSE:AIG), Alibaba Group Holding Ltd (NYSE:BABA), Zimmer Holdings, Inc. (NYSE … · 11/17/2014
Today, we'll take a closer look at one of those dividend stocks, Zimmer Holdings (NYSE: ZMH ) , and look at whether this provider ... As we know, there is no such thing as the perfect stock. Here are some headwinds which could work against Zimmer.
The Motley Fool · BySean Williams · 8/20/2014
The top biotech holding of Ghost Tree heading into 2015 was Zimmer Holdings Inc. (NYSE:ZMH), in which the fund held an 86,200 ... right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last ...
Market data is delayed at least 15 minutes.
Bloomberg · 6/17/2015
Zimmer Holdings (NYSE:ZMH) was upgraded by Robert W. Baird from a “neutral” rating to an “outperform” rating in a research note issued on Friday, reports. Shares of Zimmer Holdings (NYSE:ZMH) opened at 112.52 on Friday.
Mideast Times · 1/30/2015
That’s not a surprise. In our initial report, we classified TrovaGene as an ultra-high-risk stock, said to expect a volatile run, and recommended investors be willing to hold the shares for at least two years to ride out the big swings that almost always ...
Money Morning · 4/25/2014